Explore FHI 360

Start a New Search

Search within these results

HealthArticleClinical trials design and implementation

9 Results Found

Feature

A history of assuring quality - from contraceptives to COVID-19 vaccines

FHI 360’s Product, Quality and Compliance department is the main provider of quality assurance for USAID’s Bureau for Global Health and has supported the U.S. global response to COVID-19.
Feature

Are we ready for the next pandemic? A clinical trial for a Zika virus vaccine improves the odds

In this audio interview, Ted FitzGerald and Claudia Christian discuss the global community’s preparedness for the next pandemic and the lessons we have learned about rapidly setting up clinical trials in resource-limited countries.
Feature

The challenge of developing a clinical trial for an Ebola vaccine

The development of new vaccines and medicines is critical to responding to emerging health threats, such as Ebola. And, when lives are at stake, the response cannot be fast enough.
News

FHI 360's clinical trials expertise supports further development of a Zika virus vaccine

FHI 360 is providing monitoring services for a trial to evaluate a DNA vaccine for the Zika virus, which could protect healthy adults and adolescents.
Feature

Malaria and the impact of clinical research

In this audio interview, FHI 360’s Ted FitzGerald, Director of Global Research Services, interviews our Director of Clinical Research in Kenya, Ghiorghis (George) Belai, about the status of malaria research.
Feature

China Tuberculosis Clinical Trials Consortium will advance global TB knowledge

FHI 360 began the China Tuberculosis Clinical Trials Consortium to develop a TB clinical trials research platform that meets international standards and is able to enroll participants in global, multicenter studies.
News

ECHO Study of hormonal contraception and HIV begins

FHI 360 and partners embark on a landmark study designed to fill a critical gap in the scientific evidence on the relationship between HIV acquisition and hormonal contraceptives.
News

Study identifies ways to increase HIV testing, reduce HIV infection and detect previously undiagnosed HIV infections

Study results presented today at the Conference on Retroviruses and Opportunistic Infections by the HIV Prevention Trials Network (HPTN) and the National Institutes of Health (NIH) show that a series of community efforts can increase the number of...
News

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs

RESEARCH TRIANGLE PARK, NC — Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP...

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

A history of assuring quality - from contraceptives to COVID-19 vaccines

Are we ready for the next pandemic? A clinical trial for a Zika virus vaccine improves the odds

The challenge of developing a clinical trial for an Ebola vaccine

FHI 360's clinical trials expertise supports further development of a Zika virus vaccine

Malaria and the impact of clinical research

China Tuberculosis Clinical Trials Consortium will advance global TB knowledge

ECHO Study of hormonal contraception and HIV begins

Study identifies ways to increase HIV testing, reduce HIV infection and detect previously undiagnosed HIV infections

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs